Not applicableActive Not RecruitingNCT06833723
What this trial is testing
Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
Who this might be right for
Breast Neoplasms
Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences 1,000